PTN on Nasdaq

PALATIN TECHNOLOGIES INC

American pharmaceutical preparations company based in Cranbury.

Price unavailable

Last updated Oct 18, 2026.

Overview

$13.2MRevenue, fiscal 2026²

-$8.4MNet income, fiscal 2026²

Compare with Tonix Pharmaceuticals, Evommune, Inc. or CV Sciences, Inc., or pick any stock.

TickerPTN on Nasdaq
IndustryPharmaceutical Preparations
HeadquartersCranbury, United States
Incorporated inNJ³
Business address4B Cedar Brook Drive, Cranbury, Nj 08512³
Filer categoryNon-accelerated filer, Smaller reporting company³

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

-65.7%Operating margin²

-63.5%Net margin²

-125.3%Return on equity²

-$13.6MFree cash flow²

Where the money goes

Where each dollar of revenue went, fiscal 2026

Research and developmentIncome tax

Research and development60¢$12.4M
Income tax40¢$8.4M

Out of $13.2M in revenue.² The company lost money this year.

Financial statements

Revenue⁴⁵⁶⁷⁸⁹²$13.2M in 2026−78% since 2019

Operating income⁴⁵⁶⁷⁸⁹²-$8.7M in 2026

Net income⁴⁵⁶⁷⁸⁹²-$8.4M in 2026

Every line of the income statement as filed: the last 2 fiscal years, latest first.²

Period ending	2026-06-30	2025-06-30
Collaboration and license	$13.2M
Research and development	$12.4M	$14.9M
General and administrative	$9.5M	$7.8M
Gain on sale of Vyleesi		-$3.1M
Gain on purchase commitment		-$2.1M
Total operating expenses	$21.9M	$17.5M
Loss from operations	-$8.7M	-$17.5M
Investment income	$297.1K	$167.7K
Foreign currency transaction loss		-$50
Interest expense	-$6.7K	-$15.0K
Total other income, net	$290.4K	$152.6K
NET LOSS	-$8.4M	-$17.3M
Basic net loss per common share	-$2.96	-$32.15
Diluted net loss per common share	-$2.96	-$32.15
Weighted average number of common shares outstanding used in computing basic net loss per common share	2.8M shares	538.3K shares
Weighted average number of common shares outstanding used in computing diluted net loss per common share	2.8M shares	538.3K shares

Total assets⁴⁵⁶⁷⁸⁹²$8.5M in 2026−92% since 2019

Total liabilities⁴⁵⁶⁷⁸⁹²$1.8M in 2026−56% since 2019

Shareholders’ equity⁵⁶⁷⁸⁹²$6.7M in 2026−93% since 2019

Cash⁵⁶⁷⁸²$7.5M in 2026−83% since 2019

Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.²

Period ending	2026-06-30	2025-06-30	2024-06-30
Cash and cash equivalents	$7.5M	$2.6M
Accounts receivable	$300.8K
Other receivables		$29.5K
Prepaid expenses and other current assets	$371.7K	$325.7K
Total current assets	$8.2M	$2.9M
Property and equipment, net	$118.1K	$129.4K
Right-of-use assets - operating leases	$219.7K	$161.2K
Other assets	$21.6K	$56.9K
Total assets	$8.5M	$3.3M
Accounts payable	$1.1M	$7.0M
Accrued expenses	$504.2K	$881.4K
Short-term operating lease liabilities	$158.3K	$129.8K
Total current liabilities	$1.8M	$8.0M
Long-term operating lease liabilities	$65.4K	$34.0K
Total liabilities	$1.8M	$8.0M
Common stock of $0.01 par value authorized 300,000,000 shares: issued and outstanding 1,779,275 shares as of June 30, 2026 and 929,597 shares as of June 30, 2025	$17.8K	$9.3K
Additional paid-in capital	$474.1M	$454.3M
Accumulated deficit	-$467.5M	-$459.1M
Total stockholders equity (deficiency)	$6.7M	-$4.8M	-$111.5K
Total liabilities and stockholders equity (deficiency)	$8.5M	$3.3M
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	10.0M shares	10.0M shares
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	300.0M shares	300.0M shares
Common stock, shares issued	1.8M shares	929.6K shares
Common stock, shares outstanding	1.8M shares	929.6K shares

Period ending	2026-06-30	2025-06-30	2024-06-30
Cash and cash equivalents	$7.5M	$2.6M
Accounts receivable	$300.8K
Other receivables		$29.5K
Prepaid expenses and other current assets	$371.7K	$325.7K
Total current assets	$8.2M	$2.9M
Property and equipment, net	$118.1K	$129.4K
Right-of-use assets - operating leases	$219.7K	$161.2K
Other assets	$21.6K	$56.9K
Total assets	$8.5M	$3.3M
Accounts payable	$1.1M	$7.0M
Accrued expenses	$504.2K	$881.4K
Short-term operating lease liabilities	$158.3K	$129.8K
Total current liabilities	$1.8M	$8.0M
Long-term operating lease liabilities	$65.4K	$34.0K
Total liabilities	$1.8M	$8.0M
Common stock of $0.01 par value authorized 300,000,000 shares: issued and outstanding 1,779,275 shares as of June 30, 2026 and 929,597 shares as of June 30, 2025	$17.8K	$9.3K
Additional paid-in capital	$474.1M	$454.3M
Accumulated deficit	-$467.5M	-$459.1M
Total stockholders equity (deficiency)	$6.7M	-$4.8M	-$111.5K
Total liabilities and stockholders equity (deficiency)	$8.5M	$3.3M
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	10.0M shares	10.0M shares
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	300.0M shares	300.0M shares
Common stock, shares issued	1.8M shares	929.6K shares
Common stock, shares outstanding	1.8M shares	929.6K shares

Cash from operations⁴⁵⁶⁷⁸⁹²-$13.5M in 2026−38% since 2019

Capital spending⁴⁵⁶⁷⁸⁹²$51.3K in 2026+42% since 2019

Free cash flow⁴⁵⁶⁷⁸⁹²-$13.6M in 2026−38% since 2019

Every line of the cash flow as filed: the last 2 fiscal years, latest first.²

Period ending	2026-06-30	2025-06-30
Net loss	-$8.4M	-$17.3M
Depreciation and amortization	$62.7K	$258.9K
Decrease in right-of-use asset	$190.2K	$366.2K
Unrealized foreign currency transaction loss		$50
Stock-based compensation	$1.3M	$1.4M
Debt cancellation	-$3.8M
Gain on sale of Vyleesi		-$3.1M
Gain on purchase commitment		-$2.1M
Accounts receivable	-$300.8K
Other receivables	$29.5K	-$29.5K
Prepaid expenses and other assets	-$10.7K	-$83.4K
Accounts payable	-$2.1M	$2.9M
Accrued expenses	-$377.3K	-$3.3M
Operating lease liabilities	-$188.8K	-$380.5K
Other liabilities		$141.4K
Net cash used in operating activities	-$13.5M	-$21.3M
Proceeds from sale of Vyleesi		$3.1M
Purchases of property and equipment	-$51.3K
Net cash (used in) provided by investing activities	-$51.3K	$3.1M
Payment of withholding taxes related to restricted stock units	-$19.5K	-$99.5K
Proceeds from the sale of common stock and warrants, net	$16.9M	$8.0M
Payment of finance lease obligations		-$46.0K
Proceeds from exercise of warrants	$1.6M	$3.4M
Net cash provided by financing activities	$18.5M	$11.2M
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	$4.9M	-$7.0M
Cash paid for interest	$6.7K	$15.0K
Right-of-use assets obtained in exchange for new operating lease obligation	$248.7K

Compare PALATIN TECHNOLOGIES INC with another company

Leadership

Who has led PALATIN TECHNOLOGIES INC, and when. Pick a name to see everywhere that person has worked.

2010201520202025

Chief executive officerCarl Spana Oct 11, 2006 to now¹²
PresidentCarl Spana Oct 11, 2006 to now¹²
Chief financial officerStephen T. Wills Oct 11, 2006 to now¹³
Chief operating officerStephen T. Wills Jun 24, 2011 to now¹⁴

Board members and other officers (14)

Exec VP - OperationsStephen T. Wills Jul 3, 2008 to Jul 3, 2008¹⁵
Exec. VP Research & Dev.Trevor Hallam Oct 11, 2006 to Jul 23, 2010¹⁶
Board memberAnthony M. Manning Sep 11, 2017 to Jul 16, 2024¹⁷
Board memberArlene Morris Jun 11, 2015 to now¹⁸
Board memberAngela Rossetti Jul 3, 2013 to Jun 18, 2020¹⁹
Board memberAlan W. Dunton Jun 23, 2011 to now²⁰
Board memberErrol B. Desouza Jul 5, 2006 to Jul 23, 2010²¹
Board memberJoseph Stanley Hull Jul 5, 2006 to Jul 16, 2024²²
Board memberPerry B. Molinoff Jul 5, 2006 to Jun 27, 2014²³
Board memberRobert I. Taber Jul 5, 2006 to Jun 27, 2014²⁴
Board memberRobert K. Deveer Jr. Jul 5, 2006 to now²⁵
Board memberZola P. Horovitz Jul 5, 2006 to Dec 10, 2015²⁶
Board memberJohn K. A. Prendergast Sep 21, 2006 to now²⁷
Board memberCarl Spana Oct 11, 2006 to now¹²

Former names

INTERFILM INCJul 23, 1996 to Jun 14, 1996³

Timeline

Oct 11, 2006New chief executive Carl Spana becomes CEO¹²
Nov 21, 1986Founded PALATIN TECHNOLOGIES INC is founded²⁸

Filings

242 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 64 major events, 64 insider forms, 13 large holders, 81 other. The latest 20:

Sep 28, 202610-K EDGAR
Aug 14, 2026SCHEDULE 13G/A EDGAR
Aug 5, 20264 EDGAR
Aug 5, 20264 EDGAR
Aug 5, 20264 EDGAR
Aug 3, 20268-K EDGAR
Jul 17, 20264 EDGAR
Jul 17, 20264 EDGAR
Jun 25, 2026DEF 14A EDGAR
May 28, 20268-A12B EDGAR
May 28, 202625 EDGAR
May 28, 2026CERT EDGAR
May 18, 20268-K EDGAR
May 15, 2026SCHEDULE 13G/A EDGAR
May 15, 2026SCHEDULE 13G/A EDGAR
May 15, 2026SCHEDULE 13G EDGAR
May 13, 202610-Q EDGAR
Apr 23, 2026SCHEDULE 13G EDGAR
Feb 17, 202610-Q EDGAR
Feb 17, 2026SCHEDULE 13G EDGAR

The 242 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 13 such filings since October 2021, the latest 10:

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
Driehaus Capital Management LLC	166,713	$1.8M	0.0%	No change
Jupiter Topco LLC	140,000	$1.5M	0.0%	New
Logos Global Management LP	130,000	$1.4M	0.1%	−10,000
Ra Capital Management, L.P.	62,124	$670.3K	0.0%	−7,876
Balyasny Asset Management L.P.	41,110	$443.6K	0.0%	−59
Morgan Stanley	27,272	$294.3K	0.0%	No change
Opaleye Management Inc.	20,500	$221.2K	0.0%	New
Geode Capital Management, LLC	19,382	$209.2K	0.0%	+880
Vanguard Capital Management LLC	18,911	$204.1K	0.0%	−68
Miller Financial Services LLC	15,000	$161.8K	0.1%	+2,400
LPL Financial LLC	12,552	$135.4K	0.0%	−3
Woodline Partners LP	11,244	$121.3K	0.0%	New
Vanguard Fiduciary Trust Co	8,842	$95.4K	0.0%	+68
BlackRock, Inc.	5,652	$61.0K	0.0%	New
UBS Group AG	2,986	$32.2K	0.0%	−343
Vanguard Global Advisers, LLC	1,250	$13.5K	0.0%	No change
Tower Research Capital LLC (TRC)	593	$6.4K	0.0%	+255
Osaic Holdings, Inc.	170	$1.8K	0.0%	+1
Jones Financial Companies Lllp	155	$1.8K	0.0%	+5
Us Bancorp \de\	125	$1.3K	0.0%	No change
SBI Securities Co., Ltd.	107	$1.2K	0.0%	+94
West Paces Advisors Inc.	12	$129	0.0%	New
Barclays PLC	10	$108	0.0%	New
Wells Fargo & Company/mn	4	$43	0.0%	−4
Citigroup Inc	0	$4	0.0%	No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPALATIN TECHNOLOGIES INC filings on SEC EDGAR
2
SEC EDGARPALATIN TECHNOLOGIES INC 10-K for fiscal 2026
3
SEC EDGARPALATIN TECHNOLOGIES INC filings on SEC EDGAR
4
SEC EDGARPALATIN TECHNOLOGIES INC 10-K for fiscal 2019
5
SEC EDGARPALATIN TECHNOLOGIES INC 10-K for fiscal 2020
6
SEC EDGARPALATIN TECHNOLOGIES INC 10-K for fiscal 2021
7
SEC EDGARPALATIN TECHNOLOGIES INC 10-K for fiscal 2022
8
SEC EDGARPALATIN TECHNOLOGIES INC 10-K for fiscal 2023
9
SEC EDGARPALATIN TECHNOLOGIES INC 10-K for fiscal 2024
10
SEC EDGARPALATIN TECHNOLOGIES INC 10-Q for fiscal 2025
11
SEC EDGARPALATIN TECHNOLOGIES INC 10-Q for fiscal 2025
12
SEC EDGARCarl Spana, Chief executive officer
13
SEC EDGARStephen T. Wills, Chief financial officer
14
SEC EDGARStephen T. Wills, Chief operating officer
15
SEC EDGARStephen T. Wills, Exec VP - Operations
16
SEC EDGARTrevor Hallam, Exec. VP Research & Dev.
17
SEC EDGARAnthony M. Manning, Board member
18
SEC EDGARArlene Morris, Board member
19
SEC EDGARAngela Rossetti, Board member
20
SEC EDGARAlan W. Dunton, Board member
21
SEC EDGARErrol B. Desouza, Board member
22
SEC EDGARJoseph Stanley Hull, Board member
23
SEC EDGARPerry B. Molinoff, Board member
24
SEC EDGARRobert I. Taber, Board member
25
SEC EDGARRobert K. Deveer Jr., Board member
26
SEC EDGARZola P. Horovitz, Board member
27
SEC EDGARJohn K. A. Prendergast, Board member
28
gleifPALATIN TECHNOLOGIES INC is founded